Table 1.
Serpin | RSL hinge*
|
RSL variable
|
kass (105 M−1⋅s−1)†
|
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P 15 | 14 | 13 | 12 | 11 | 10 | 9 | 8 | 7 | 6 | 5 | 4 | 3 | 2 | 1 | 1′ | 2′ | 3′ | 4′ | 5′ | catS | catG | try | CT | |
Wild types | ||||||||||||||||||||||||
SCCA2 | G | V | E | A | A | A | A | T | A | V | V | V | V | E | L | S | S | P | S | T | 0 | 1.0‡ | 0 | 0 |
SCCA1 | G | A | E | A | A | A | A | T | A | V | V | G | F | G | S | S | P | T | S | T | 1.0§ | 0 | 0 | 0 |
Mutants | ||||||||||||||||||||||||
AlaP14Arg | . | R | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | 0 | 0 | 0 | |
AlaP14Thr | . | T | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | 3.9 | 0 | 0 | |
SCCA1(2) | . | V | . | . | . | . | . | . | . | . | . | V | V | E | L | S | S | P | . | . | 0 | 0.7 | ||
SCCA2(1)¶ | . | A | . | . | . | . | . | . | . | . | . | G | F | G | S | S | P | T | . | . | 1.2 | 0 | ||
GlyP2Arg | . | . | . | . | . | . | . | . | . | . | . | . | . | R | . | . | . | . | . | . | 0.2 | 0 | 0.4 | 0 |
GlyP2Glu | . | . | . | . | . | . | . | . | . | . | . | . | . | E | . | . | . | . | . | . | 1.1 | 0 | ||
PheP3Ala | . | . | . | . | . | . | . | . | . | . | . | . | A | . | . | . | . | . | . | . | 0 | 0 | ||
PheP3Leu | . | . | . | . | . | . | . | . | . | . | . | . | L | . | . | . | . | . | . | . | 3.3 | 0 | 0 | |
ThrP3′Ala | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . | A | . | . | 0.9 | 0 | 0 |
Schecter and Berger numbering scheme (13), but, for comparative purposes, numbering relative to conserved P15Gly.
catS, cathepsin S; catG, cathepsin G; try, trypsin; CT, chymotrypsin. Second-order rate constants were calculated under second-order conditions (catG) and pseudo-first-order conditions (catS and trypsin). 0, no inhibition seen under conditions used.
Ref. 12.
Ref. 11.
SCCA2 framework with SCCA1 RSL.